VERONA PHARMA PLC - ADR (VRNA)
US9250501064 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -54.37M | -68.70M | -55.57M | -65.15M | -40.56M | |||
| Depreciation Amortization | 677.00K | 640.00K | 630.00K | 620.00K | 510.00K | |||
| Change In Working Capital | -13.90M | -10.74M | -1.56M | -2.11M | -4.27M | |||
| Interest Paid | 2.01M | 350.00K | 220.00K | 10.00K | 0.00 | |||
| Taxes Paid | 1.25M | 120.00K | 0.00 | 10.00K | 0.00 | |||
| Other non cash items | 17.37M | 18.94M | 23.24M | 21.56M | 1.45M | |||
| OPERATING CASH FLOW | -50.22M | -59.86M | -33.25M | -45.08M | -42.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -30.00K | -10.00K | -80.00K | -50.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | 9.79M | 47.37M | |||
| INVESTING CASH FLOW | 0.00 | -30.00K | -10.00K | 9.71M | 47.31M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 38.71M | 5.00M | 0.00 | 5.00M | 0.00 | |||
| Stock Issued/Repurchased | 1.95M | 151.17M | 730.00K | 200.20M | 0.00 | |||
| Other Financing Activity | 52.21M | -15.35M | -6.85M | -12.86M | 0.00 | |||
| FINANCING CASH FLOW | 92.87M | 140.82M | -6.12M | 192.34M | 0.00 | |||
| Exchange Rate Effect | 1.30M | -1.48M | -220.00K | 580.00K | 740.00K | |||
| CHANGE IN CASH | 43.95M | 79.45M | -39.60M | 157.55M | 5.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -50.22M | -59.86M | -33.25M | -45.08M | -42.87M | |||
| Capital Expenditure | 0.00 | -30.00K | -10.00K | -80.00K | -50.00K | |||
| FREE CASH FLOW | -50.22M | -59.89M | -33.26M | -45.16M | -42.92M | |||
All data in USD